Journalartikel
Autorenliste: Witsch, Thilo J.; Niess, Gero; Sakkas, Elpidoforos; Likhoshvay, Tatyana; Becker, Simone; Herold, Susanne; Mayer, Konstantin; Vadasz, Istvan; Roberts, Jesse D., Jr.; Seeger, Werner; Morty, Rory E.
Jahr der Veröffentlichung: 2014
Seiten: 109-121
Zeitschrift: European Respiratory Journal
Bandnummer: 44
Heftnummer: 1
ISSN: 0903-1936
eISSN: 1399-3003
Open Access Status: Green
DOI Link: https://doi.org/10.1183/09031936.00075713
Verlag: European Respiratory Society
Aberrant remodelling of the extracellular matrix in the developing lung may underlie arrested alveolarisation associated with bronchopulmonary dysplasia (BPD). Transglutaminases are regulators of extracellular matrix remodelling. Therefore, the expression and activity of transglutaminases were assessed in lungs from human neonates with BPD and in a rodent model of BPD. Transglutaminase expression and localisation were assessed by RT-PCR, immunoblotting, activity assay and immunohistochemical analyses of human and mouse lung tissues. Transglutaminase regulation by transforming growth factor (TGF)-beta was investigated in lung cells by luciferase-based reporter assay and RT-PCR. TGF-beta signalling was neutralised in vivo in an animal model of BPD, to determine whether TGF-beta mediated the hyperoxia-induced changes in transglutaminase expression. Transglutaminase 2 expression was upregulated in the lungs of preterm infants with BPD and in the lungs of hyperoxia-exposed mouse pups, where lung development was arrested. Transglutaminase 2 localised to the developing alveolar septa. TGF-beta was identified as a regulator of transglutaminase 2 expression in human and mouse lung epithelial cells. In vivo neutralisation of TGF-beta signalling partially restored normal lung structure and normalised lung transglutaminase 2 mRNA expression. Our data point to a role for perturbed transglutaminase 2 activity in the arrested alveolarisation associated with BPD.
Abstract:
Zitierstile
Harvard-Zitierstil: Witsch, T., Niess, G., Sakkas, E., Likhoshvay, T., Becker, S., Herold, S., et al. (2014) Transglutaminase 2: a new player in bronchopulmonary dysplasia?, European Respiratory Journal, 44(1), pp. 109-121. https://doi.org/10.1183/09031936.00075713
APA-Zitierstil: Witsch, T., Niess, G., Sakkas, E., Likhoshvay, T., Becker, S., Herold, S., Mayer, K., Vadasz, I., Roberts, J., Seeger, W., & Morty, R. (2014). Transglutaminase 2: a new player in bronchopulmonary dysplasia?. European Respiratory Journal. 44(1), 109-121. https://doi.org/10.1183/09031936.00075713
Schlagwörter
FIBROSIS; GROWTH-FACTOR-BETA; lung development; TISSUE TRANSGLUTAMINASE